Assessing Psoriasis Treatment Outcomes

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07391423
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Artificial intelligence — BEHAVIORAL
    patients will receive BD and have a weekly virtual visit with an AIGPP
  • Human — BEHAVIORAL
    patients will receive BD and receive weekly video calls from study staff
  • Standard of Care — OTHER
    patients will receive BD and scheduled for a single follow up visit in 4 weeks

Study Details

To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.

Key Dates

Start date
Jul 31, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2028
Completion
Mar 31, 2029

Study Design

Enrollment
15 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: AI intervention group
    Subject will receive with topical betamethasone dipropionate cream (BD) and have a weekly virtual visit with an AI-generated automated physician provider (AIGPP).
  • Experimental: Human intervention group
    Subjects will receive BD and receive weekly video calls from study staff
  • Other: Standard of Care Group
    Subjects will receive BD and scheduled for a single follow up visit in 4 weeks

Primary Outcome Measure

Ability to implement AIGPP system and Rate of dropout in AIGPP trial arm [ Time Frame: Week 4 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Wake Forest University Health Sciences Department of DermatologyWinston-SalemNorth Carolina27157
Irma M Richardson, MHA
[email protected]
336-716-2903
336-716-7465
Steven R Feldman, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Winston-Salem, NC

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Wake Forest University Health Sciences Department of Dermatology· Winston-Salem, NC

Related Studies